Brain Diseases  >>  zolmitriptan  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
zolmitriptan / Generic mfg.
NCT00617747: Efficacy and Tolerability of Zolmitriptan Nasal Spray

Completed
3
2114
US
Zolmitriptan, Zomig, Placebo
AstraZeneca
Migraine
 
06/03
NCT00617695: Efficacy of Zolmitriptan (Zomig) in the Treatment of Migraines in Adolescents

Completed
3
247
US
Zolmitriptan, Zomig, Placebo
AstraZeneca
Migraine
 
10/04
NCT00442936: Study of Telcagepant (MK-0974) in Participants With Moderate to Severe Acute Migraine With or Without Aura (MK-0974-011)

Completed
3
1380
NA
Telcagepant potassium 150 mg, Telcagepant potassium 300 mg, Zolmitriptan 5 mg, Placebo to telcagepant 150 mg, Placebo to tecagepant 300 mg, Placebo to zolmitriptan 5 mg, Rescue medication
Merck Sharp & Dohme LLC
Migraine
10/07
10/07

Download Options